TaiwanJ Pharmaceuticals Co., Ltd. (6549.TWO)
TWD 7.93
(-1.25%)
TWD 7.93
(-1.25%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 22.74 Million | 15.35 Million | 22.05 Million | - | 61.72 Million |
| Cost of Revenue | - | 75.27 Million | - | - | 20.28 Million |
| Gross Profit | 22.74 Million | -59.92 Million | 22.05 Million | - | 41.43 Million |
| Operating Expenses | 29.35 Million | 25.72 Million | 31.78 Million | 40.37 Million | 41.01 Million |
| Selling, General and Administrative Expenses | 15.37 Million | 12.98 Million | 14.05 Million | 14.39 Million | 22.01 Million |
| Research and Development Expenses | 13.97 Million | 12.74 Million | 17.73 Million | 25.98 Million | 26.11 Million |
| Other Expenses | - | 3.44 Million | -615 Thousand | -2.13 Million | - |
| Cost and Expenses | 29.35 Million | 101 Million | 31.78 Million | 40.37 Million | 61.29 Million |
| Operating Income | -6.61 Million | -81.7 Million | -10.3 Million | -42.43 Million | -6.68 Million |
| Interest Expense | 24 Thousand | 10 Thousand | 13 Thousand | 25 Thousand | 23 Thousand |
| Income Tax Expense | 2.27 Million | - | 2.1 Million | - | 6.17 Million |
| Earnings before Tax | -3.77 Million | -92.46 Million | -10.31 Million | -42.45 Million | 1.08 Million |
| Net Income | -6.04 Million | -92.46 Million | -12.42 Million | -42.45 Million | -5.08 Million |
| Earnings Per Share Basic | -0.08 | -1.23 | -0.17 | -0.60 | -0.07 |
| Earnings Per Share Diluted | -0.08 | -1.23 | -0.17 | -0.60 | -0.07 |
| Weighted Average Shares Outstanding | 75.47 Million | 75.12 Million | 75.1 Million | 70.8 Million | 68.75 Million |
| Weighted Average Shares Outstanding (Diluted) | 75.47 Million | 75.12 Million | 75.1 Million | 70.8 Million | 68.75 Million |
| Gross Margin | 1.00 | -3.90 | 1.00 | - | 0.67 |
| EBIT Margin | -0.08 | -0.34 | -0.41 | - | 0.23 |
| Profit Margin | -0.27 | -6.02 | -0.56 | - | -0.08 |
| EBITDA | -1.73 Million | -15.99 Million | -9.14 Million | -41.02 Million | 13.94 Million |
| Earnings Before Tax Margin | -0.29 | -5.32 | -0.47 | - | -0.11 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | 22.74 Million | - | 11.37 Million |
| Cost of Revenue | 981 Thousand | - | - | - | - | - |
| Gross Profit | -981 Thousand | - | - | 22.74 Million | - | 11.37 Million |
| Operating Expenses | 6.74 Million | 5.46 Million | 9.78 Million | 29.35 Million | 9.78 Million | 4.71 Million |
| Selling, General and Administrative Expenses | 3.86 Million | 3.86 Million | 4.26 Million | - | 4.26 Million | 3.42 Million |
| Research and Development Expenses | 2.88 Million | 2.88 Million | 5.18 Million | - | 5.18 Million | 1.8 Million |
| Other Expenses | - | - | - | 345 Thousand | - | - |
| Cost and Expenses | 6.74 Million | 5.46 Million | 9.78 Million | 29.35 Million | 9.78 Million | 4.71 Million |
| Operating Income | -6.74 Million | -6.74 Million | -9.45 Million | -3.74 Million | -9.45 Million | 6.14 Million |
| Interest Expense | - | - | - | 24 Thousand | - | - |
| Income Tax Expense | - | - | - | 2.27 Million | - | 1.13 Million |
| Earnings before Tax | -4.84 Million | -4.84 Million | -9.03 Million | -3.77 Million | -9.03 Million | 7.14 Million |
| Net Income | -4.84 Million | -4.84 Million | -9.03 Million | -6.04 Million | -9.03 Million | 6.01 Million |
| Earnings Per Share Basic | -0.06 | -0.06 | -0.12 | - | -0.12 | 0.08 |
| Earnings Per Share Diluted | -0.06 | -0.06 | -0.12 | - | -0.12 | 0.08 |
| Weighted Average Shares Outstanding | 74.51 Million | 74.51 Million | 74.7 Million | 75.12 Million | 74.7 Million | 75.13 Million |
| Weighted Average Shares Outstanding (Diluted) | 75.12 Million | 74.51 Million | 75.12 Million | 75.12 Million | 75.12 Million | 75.99 Million |
| Gross Margin | - | - | - | 1.00 | - | 1.00 |
| EBIT Margin | - | - | - | - | - | 0.57 |
| Profit Margin | - | - | - | -0.27 | - | 0.53 |
| EBITDA | -6.42 Million | -6.25 Million | -9.09 Million | - | -9.09 Million | 6.45 Million |
| Earnings Before Tax Margin | - | - | - | -0.16 | - | 0.54 |
GXAI
6625
412540
RWCB
IDNT
6198